STAUROSPORINE DERIVATIVES AS INHIBITORS OF FLT3 RECEPTOR TYROSINE KINASE ACTIVITY
摘要
The present invention relates to the use of staurosporines derivatives for the preparation of a drug for the treatment of diseases involving deregulated FLT3 receptor tyrosine kinase activity, especially for the curative and/or prophylactic treatment of leukemias and myelodysplastic syndromes, and to a method of treating diseases involving deregulated FLT3 receptor tyrosine kinase activity.
申请公布号
WO03037347(A1)
申请公布日期
2003.05.08
申请号
WO2002EP12076
申请日期
2002.10.29
申请人
NOVARTIS AG;NOVARTIS PHARMA GMBH;DANA-FARBER CANCER INSTITUTE INC.;GRIFFIN, JAMES, DOUGLAS;MANLEY, PAUL, WILLIAM